Chargement en cours...
Cellular factors promoting resistance to effective treatment of glioma with oncolytic Myxoma virus
Oncolytic virus therapy is being evaluated in clinical trials for human glioma. While it is widely assumed that the patient's immune response to the virus infection limits the therapy's utility, investigations into the specific cell type(s) involved in this response have been performed usi...
Enregistré dans:
| Publié dans: | Cancer Res |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281961/ https://ncbi.nlm.nih.gov/pubmed/25336188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0876 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|